ROLE OF THE COURT
11 Section 411(4) of the Act provides that a members' scheme of arrangement is binding if, at a meeting of members, it is agreed to by the requisite majorities of members present and voting and by number of votes cast, and it is subsequently approved by order of the Court.
12 Before approving a scheme, the Court needs to be satisfied not only that the resolution to agree to the scheme has been passed in accordance with the statutory majorities, but that all other statutory and procedural requirements in relation to the convening and conduct of the meeting have been observed: Re AWA Mutual Limited (No 2) [2024] FCA 104 at [12] (Anderson J); Re iSelect Ltd (2022) 166 ACSR 41 at [7] (Anderson J); Re ResApp Health Ltd [2022] NSWSC 1353 at [23] (Black J); Re Tabcorp Holdings Ltd (No 2) [2022] NSWSC 725 at [3] (Black J); Re Afterpay Limited [2021] NSWSC 1709 at [14] (Black J); Re Isentia Group Limited [2021] NSWSC 1069 at [9] (Black J).
13 In particular, the Court must be satisfied that the meeting was properly convened and conducted in accordance with the orders made at the first Court hearing, and that all requirements of the Act and the Federal Court (Corporations) Rules 2000 (Cth) have been complied with: Re AWA at [12]; Re iSelect at [7]; Re Costa Group Holdings Limited [2024] FCA 59 at [11] (O'Callaghan J).
14 Once satisfied that all statutory and procedural requirements have been met, the Court has a discretion to approve a scheme pursuant to s 411(4)(b) of the Act.
15 Although the Court is not bound to approve a scheme simply because it has previously made orders for the convening of a scheme meeting and the statutory majorities have been achieved, the Court will recognise that shareholders are generally the best judges of whether an arrangement is to their commercial advantage and, accordingly, absent good reason, will give effect to their intentions as manifested in the voting at the scheme meeting: Re iSelect at [10]; Re Costa at [13]; Re ResApp Health at [23]; Re Probiotec Limited (No 2) [2024] FCA 593 at [33] (Button J). In this respect, the Court accepts that the shareholders' vote in favour of a scheme is evidence of its inherent fairness. Put another way, if a majority of the shareholders approve a scheme, it is unlikely that the scheme would be considered unreasonable: Re iSelect at [11]; Re Crown Resorts Limited (No 2) [2022] FCA 710 at [11]-[12] (Anderson J); Re Amcor (No 2) [2019] FCA 842 at [11] (Beach J).
16 The considerations relevant to the exercise of the Court's discretion to approve a scheme are well established, and they have been considered in a number of decisions: Re AWA at [11]-[14]; Re iSelect at [8] - [12]; Re Carbon Revolution Limited (No 3) [2023] FCA 1270 at [12]-[14] (Moshinsky J); Re Probiotec at [8]; Re Amcor at [7] to [11]; Re Japara Healthcare Limited [2021] FCA 1150 at [11] - [13] (Moshinsky J). Those decisions demonstrate that the Court will ordinarily have regard to the following matters:
(a) that the scheme was approved by shareholders acting in good faith and for proper purposes, and there is no suggestion of oppression of any minority;
(b) that there was full and fair disclosure to members of all information material to the decision whether to vote for or against the scheme;
(c) that the scheme is fair and reasonable so that an intelligent and honest shareholder, properly informed and acting alone, might approve it;
(d) that all matters that could be considered relevant to the exercise of the Court's discretion have been drawn to the Court's attention, and that ASIC has been given the opportunity to draw the Court's attention to any relevant matter;
(e) that the conditions precedent to the scheme have been satisfied or waived (save for conditions relating to Court-approval); and
(f) that the Court is satisfied under s 411(17) that the scheme has not been proposed to avoid Chapter 6 of the Act, or there is a statement from ASIC that it has no objection to the scheme.
17 Midway submitted, and I accept, that each of these matters has been satisfied in relation to the present Scheme.